HBIO
Price
$0.48
Change
+$0.01 (+2.13%)
Updated
Sep 5, 04:58 PM (EDT)
Capitalization
20.84M
62 days until earnings call
NPCE
Price
$9.75
Change
+$0.14 (+1.46%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
317.91M
67 days until earnings call
Interact to see
Advertisement

HBIO vs NPCE

Header iconHBIO vs NPCE Comparison
Open Charts HBIO vs NPCEBanner chart's image
Harvard Bioscience
Price$0.48
Change+$0.01 (+2.13%)
Volume$10.83K
Capitalization20.84M
Neuropace
Price$9.75
Change+$0.14 (+1.46%)
Volume$4.3K
Capitalization317.91M
HBIO vs NPCE Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. NPCE commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and NPCE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HBIO: $0.47 vs. NPCE: $9.61)
Brand notoriety: HBIO and NPCE are both not notable
HBIO represents the Pharmaceuticals: Other, while NPCE is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 42% vs. NPCE: 108%
Market capitalization -- HBIO: $20.84M vs. NPCE: $317.91M
HBIO [@Pharmaceuticals: Other] is valued at $20.84M. NPCE’s [@Medical/Nursing Services] market capitalization is $317.91M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileNPCE’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • NPCE’s FA Score: 0 green, 5 red.
According to our system of comparison, both HBIO and NPCE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 2 TA indicator(s) are bullish while NPCE’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 2 bullish, 5 bearish.
  • NPCE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NPCE is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а -10.05% price change this week, while NPCE (@Medical/Nursing Services) price change was +5.49% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.39%. For the same industry, the average monthly price growth was +7.03%, and the average quarterly price growth was +18.51%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.21%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +24.78%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 06, 2025.

NPCE is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.21% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NPCE($318M) has a higher market cap than HBIO($20.8M). NPCE YTD gains are higher at: -14.120 vs. HBIO (-77.825). NPCE has higher annual earnings (EBITDA): -15.52M vs. HBIO (-46.8M). NPCE has more cash in the bank: 62.1M vs. HBIO (7.44M). HBIO has less debt than NPCE: HBIO (43.3M) vs NPCE (71.5M). HBIO (88.8M) and NPCE (88.6M) have equivalent revenues.
HBIONPCEHBIO / NPCE
Capitalization20.8M318M7%
EBITDA-46.8M-15.52M302%
Gain YTD-77.825-14.120551%
P/E RatioN/AN/A-
Revenue88.8M88.6M100%
Total Cash7.44M62.1M12%
Total Debt43.3M71.5M61%
FUNDAMENTALS RATINGS
HBIO: Fundamental Ratings
HBIO
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HBIONPCE
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NPCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMNEY104.043.74
+3.73%
Siemens Energy AG
SKHHY14.970.11
+0.74%
Sonic Healthcare Ltd.
NPPNY5.37N/A
N/A
Nippon Shinyaku Co. Ltd.
EGPLF0.10N/A
N/A
Eagle Plains Resources Ltd.
GLNLF0.11N/A
N/A
GALAN LITHIUM LTD.

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-1.29%
IRMD - HBIO
51%
Loosely correlated
+2.18%
SGHT - HBIO
39%
Loosely correlated
-1.84%
A - HBIO
38%
Loosely correlated
+2.60%
TMO - HBIO
35%
Loosely correlated
+1.02%
MTD - HBIO
35%
Loosely correlated
+1.51%
More

NPCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NPCE has been loosely correlated with STVN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NPCE jumps, then STVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NPCE
1D Price
Change %
NPCE100%
+2.67%
STVN - NPCE
37%
Loosely correlated
-1.12%
HBIO - NPCE
32%
Poorly correlated
-1.29%
SMTI - NPCE
30%
Poorly correlated
+1.58%
NTRA - NPCE
30%
Poorly correlated
-0.58%
ATRC - NPCE
29%
Poorly correlated
+2.56%
More